EpiMedica · 6 days ago
Fractional Head of Business Development (Biotech / Longevity)
United States
Full-time
Remote
Senior Level, Lead/Staff
10+ years expEpiMedica is an epigenetics-driven biotechnology company focused on developing a reversible senescence control platform. They are seeking an experienced fractional Head of Business Development to lead early-stage partnership and licensing efforts in biotechnology and longevity platforms.
Biotechnology
Responsibilities
Lead outreach and negotiations for strategic partnerships, licensing, or co-development agreements
Identify and engage potential partners in:
Biotech and oncology platforms
Longevity and aging-focused companies
Shape and communicate EpiMedica’s commercial narrative (platform value, monetization paths, optionality)
Structure early non-dilutive deals, LOIs, or option-to-license agreements
Advise on partnership strategy that supports future fundraising
Work directly with the CEO and CSO to align scientific data with commercial positioning
Qualification
Required
10+ years in business development, licensing, or strategic partnerships
Prior experience in biotech or pharma
Prior experience in longevity or aging-related platforms
Demonstrated track record of closing licensing or partnership deals
Demonstrated track record of working with scientific founders
Demonstrated track record of translating complex biology into commercial value
Existing network within pharma, biotech, or global beauty companies
Comfortable working fractionally with early-stage companies
Benefits
Equity grant (advisor-level, commensurate with involvement)
Success-based fees tied to executed deals
Cash compensation as partnerships close
Flexible structure designed to scale with traction
Company
EpiMedica
EpiMedica is a translational biology platform focused on targeting senescence as a core driver of disease across oncology and aging.
11-50 employees
Funding
Current Stage
Early StageCompany data provided by crunchbase